Skip to main content
Caplight Logo









Sub-Q Bionics

Sub-Q Bionics

Private
Stillwater, MinnesotaHealthcare & Life Scienceshttps://subqbionics.com/

Last Round

Pre Seed

Mar 31, 2026

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sub-Q Bionics is a medical technology company developing an implantable bionic lymphatic drainage system to manage lymphedema for cancer survivors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

medical devicelymphedema treatmentimplantable bionicslymphatic drainagemedtechbionic implantoncology supportsurgical implantsmart implantbioelectronicsreconstructive surgerywearable alternativeimplantable pump

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sub-Q Bionics Comparables

Compare Sub-Q Bionics with similar companies based on industry and business-model similarity.

Sub-Q Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lymphatica Medtech SA
81%
Fibralign Corporation
65%
Sequana Medical NV
60%

Sub-Q Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 31, 2026
Pre SeedMar 31, 2026

Key People

Founding team and executive leadership

David M. Knapp

Chief Technology Officer

Executive Team

Sub-Q Bionics Investors

Notable investors and investment history

Sub-Q Bionics investors
InvestorRounds
Israel Innovation AuthorityPre Seed
Mayo Clinic VenturesPre Seed
Yeda Research and Development Company Ltd.Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 82% MoM, reaching 1K.

  • Mar 31, 2026

    $1.5M raised in Pre Seed round.

Sub-Q Bionics Filings

Explore SEC and related filing metadata, where available.

Sub-Q Bionics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sub-Q Bionics's valuation, stock price, and market status.

Is Sub-Q Bionics a public or private company?

Sub-Q Bionics is a private company.

What is the current stock price of Sub-Q Bionics?

Sub-Q Bionics is a private company with no public stock price. No recent secondary market data is available.

How much is Sub-Q Bionics worth (valuation)?

Valuation information for Sub-Q Bionics is not publicly available.

Can I buy Sub-Q Bionics stock?

Sub-Q Bionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sub-Q Bionics's last funding round?

Sub-Q Bionics's most recent funding round was Pre Seed on March 31, 2026.

Who are the main investors in Sub-Q Bionics?

Key investors in Sub-Q Bionics include Mayo Clinic Ventures, Yeda Research and Development Company Ltd..

Will Sub-Q Bionics IPO soon?

No public IPO plans have been announced for Sub-Q Bionics.

How can I track Sub-Q Bionics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sub-Q Bionics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStillwater, Minnesota
Employee Range4
Year Founded2025
Last FundingMar 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?